Medicover AB
OTC:MCVEY

Watchlist Manager
Medicover AB Logo
Medicover AB
OTC:MCVEY
Watchlist
Price: 16.55 USD Market Closed
Market Cap: $1.2B

Wall St Price Targets

MCVEY Price Targets Summary
Medicover AB

There are no price targets for MCVEY.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Medicover AB Competitors:
Price Targets
AVAH
Aveanna Healthcare Holdings Inc
24% Upside
ALG
Alamo Group Inc
26% Upside
CNC
Concurrent Technologies PLC
13% Upside
DVA
DaVita Inc
-10% Downside
SMMT
Summit Therapeutics Inc
101% Upside

Revenue
Forecast

19% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
19% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 3 years is 12%.

Gross Profit
Forecast

18% / Year
Past Growth
41% / Year
Estimated Growth
Estimates Accuracy
-46%
Average Miss
18% / Year
Past Growth
41% / Year
Estimated Growth
Estimates Accuracy
-46%
Average Miss

Over the last 9 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 41%.

Operating Income
Forecast

25% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
25% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

Over the last 9 years, the compound annual growth rate for Operating Income has been 25%. The projected CAGR for the next 3 years is 24%.

Pre-Tax Income
Forecast

26% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
26% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 26%. The projected CAGR for the next 3 years is 33%.

Net Income
Forecast

32% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss
32% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Over the last 9 years, the compound annual growth rate for Net Income has been 32%. The projected CAGR for the next 3 years is 29%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MCVEY's stock price target?
Not Available

MCVEY does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Medicover AB?
Projected CAGR
12%

Over the last 9 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 3 years is 12%.

What is the Gross Profit forecast for Medicover AB?
Projected CAGR
41%

Over the last 9 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 41%.

What is the Operating Income forecast for Medicover AB?
Projected CAGR
24%

Over the last 9 years, the compound annual growth rate for Operating Income has been 25%. The projected CAGR for the next 3 years is 24%.

What is the Pre-Tax Income forecast for Medicover AB?
Projected CAGR
33%

Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 26%. The projected CAGR for the next 3 years is 33%.

What is the Net Income forecast for Medicover AB?
Projected CAGR
29%

Over the last 9 years, the compound annual growth rate for Net Income has been 32%. The projected CAGR for the next 3 years is 29%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett